Single agents vs combination chemotherapy in relapsed and refractory peripheral T-cell lymphoma: Results from the comprehensive oncology measures for peripheral T-cell lymphoma treatment (COMPLETE) registry

Single agents have demonstrated activity in relapsed and refractory (R/R) peripheral T-cell lymphoma (PTCL). Their benefit relative to combination chemotherapy remains undefined. Patients with histologically confirmed PTCL were enrolled in the Comprehensive Oncology Measures for Peripheral T-cell Ly...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Hematol
Main Authors: Stuver, Robert N., Khan, Niloufer, Schwartz, Marc, Acosta, Mark, Federico, Massimo, Gisselbrecht, Christian, Horwitz, Steven M., Lansigan, Frederik, Pinter-Brown, Lauren C., Pro, Barbara, Shustov, Andrei R., Foss, Francine M., Jain, Salvia
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7928240/
https://ncbi.nlm.nih.gov/pubmed/30896890
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.25463
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados